YQBS Improves Cognitive Dysfunction in Diabetic Rats: Possible Association with Tyrosine and Tryptophan Metabolism

References

• IDF Diabetes Atlas. IDF diabetes atlas, 10th edn [EB/OL]; 2021. Available from: https://www.diabetesatlas.org. Accessed March 24, 2023.
   Google Scholar
• Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann NY Acad Sci. 2015;1353:60–71. doi:10.1111/nyas.12807
   PubMed Web of Science ®Google Scholar
• Shalimova A, Graff B, Gąsecki D, et al. Cognitive dysfunction in type 1 diabetes mellitus. J Clin Endocrinol Metab. 2019;104(6):2239–2249. doi:10.1210/jc.2018-01315
   PubMed Web of Science ®Google Scholar
• Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–545. doi:10.1016/S2213-8587(20)30118-2
   PubMed Web of Science ®Google Scholar
• Thomassen JQ, Tolstrup JS, Benn M, Frikke-Schmidt R. Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals. Epidemiol Psychiatr Sci. 2020;29:e118. doi:10.1017/S2045796020000347
   PubMed Web of Science ®Google Scholar
• Reinke C, Buchmann N, Fink A, et al. Diabetes duration and the risk of dementia: a cohort study based on German health claims data. Age Ageing. 2022;51(1). doi:10.1093/ageing/afab231
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. doi:10.1038/s41574-018-0048-7
   PubMed Web of Science ®Google Scholar
• Liu DS, Gao W, Lin -W-W, et al. Effects of the Chinese Yi-Qi-Bu-Shen Recipe extract on brainstem auditory evoked potential in rats with diabetes. J Ethnopharmacol. 2011;137(1):414–420. doi:10.1016/j.jep.2011.05.033
   PubMed Web of Science ®Google Scholar
• Liu DS, Zhou YH, Liang ES, et al. Neuroprotective effects of the Chinese Yi-Qi-Bu-Shen recipe extract on injury of rat hippocampal neurons induced by hypoxia/reoxygenation. J Ethnopharmacol. 2013;145(1):168–174. doi:10.1016/j.jep.2012.10.046
   PubMed Web of Science ®Google Scholar
• Goyal SN, Reddy NM, Patil KR, et al. Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact. 2016;244:49–63. doi:10.1016/j.cbi.2015.11.032
   PubMed Web of Science ®Google Scholar
• Tanbek K, Ozerol E, Yilmaz U, et al. Alpha lipoic acid decreases neuronal damage on brain tissue of STZ-induced diabetic rats. Physiol Behav. 2022;248:113727. doi:10.1016/j.physbeh.2022.113727
   PubMed Web of Science ®Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858. doi:10.1038/nprot.2006.116
   PubMed Web of Science ®Google Scholar
• Ghasemi R, Zarifkar A, Rastegar K, et al. Insulin protects against Abeta-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption. Neuropharmacology. 2014;85:113–120. doi:10.1016/j.neuropharm.2014.01.036
   PubMed Web of Science ®Google Scholar
• Tian H, Ding N, Guo M, et al. Analysis of learning and memory ability in an alzheimer’s disease mouse model using the Morris water maze. J Vis Exp. 2019;152. doi:10.3791/60055
   Google Scholar
• Ward R, Li W, Abdul Y, et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res. 2019;142:237–250. doi:10.1016/j.phrs.2019.01.035
   PubMed Web of Science ®Google Scholar
• Zhang JH, Zhang J-F, Song J, et al. Effects of berberine on diabetes and cognitive impairment in an animal model: the mechanisms of action. Am J Chin Med. 2021;49(6):1399–1415. doi:10.1142/S0192415X21500658
   PubMedGoogle Scholar
• Chandrasekaran K, Choi J, Arvas MI, et al. Nicotinamide mononucleotide administration prevents experimental diabetes-induced cognitive impairment and loss of hippocampal neurons. Int J Mol Sci. 2020;21(11):3756. doi:10.3390/ijms21113756
   PubMed Web of Science ®Google Scholar
• Ramos-Rodriguez JJ, Infante-Garcia C, Galindo-Gonzalez L, et al. Increased spontaneous central bleeding and cognition impairment in APP/PS1 mice with poorly controlled diabetes mellitus. Mol Neurobiol. 2016;53(4):2685–2697. doi:10.1007/s12035-015-9311-2
   PubMed Web of Science ®Google Scholar
• Datusalia AK, Sharma SS. Amelioration of diabetes-induced cognitive deficits by GSK-3beta inhibition is attributed to modulation of neurotransmitters and neuroinflammation. Mol Neurobiol. 2014;50(2):390–405. doi:10.1007/s12035-014-8632-x
   PubMed Web of Science ®Google Scholar
• Han X, Min M, Wang J, et al. Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat. J Neurosci Res. 2018;96(1):138–150. doi:10.1002/jnr.24098
   PubMed Web of Science ®Google Scholar
• Chu X, Zhou S, Sun R, et al. Chrysophanol relieves cognition deficits and neuronal loss through inhibition of inflammation in diabetic mice. Neurochem Res. 2018;43(4):972–983. doi:10.1007/s11064-018-2503-1
   PubMed Web of Science ®Google Scholar
• Jing GC, Liu D, Liu Y-Q, et al. Nao-Fu-Cong ameliorates diabetic cognitive dysfunction by inhibition of JNK/CHOP/Bcl2-mediated apoptosis in vivo and in vitro. Chin J Nat Med. 2020;18(9):704–713. doi:10.1016/S1875-5364(20)60009-7
   PubMed Web of Science ®Google Scholar
• Sun X, Li S, Xu L, et al. Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2/IRS-1 pathway in diabetic rats. Physiol Behav. 2017;174:162–169. doi:10.1016/j.physbeh.2017.03.020
   PubMed Web of Science ®Google Scholar
• Bi T, Feng R, Zhan L, et al. ZiBuPiYin Recipe prevented and treated cognitive decline in ZDF rats with diabetes-associated cognitive decline via microbiota-gut-brain axis dialogue. Front Cell Dev Biol. 2021;9:651517. doi:10.3389/fcell.2021.651517
   PubMed Web of Science ®Google Scholar
• Wang K, Chen Q, Wu N, et al. Berberine ameliorates spatial learning memory impairment and modulates cholinergic anti-inflammatory pathway in diabetic rats. Front Pharmacol. 2019;10:1003. doi:10.3389/fphar.2019.01003
   PubMed Web of Science ®Google Scholar
• Wei Y, Luo Q-L, Sun J, et al. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model. J Ethnopharmacol. 2015;164:368–377. doi:10.1016/j.jep.2015.01.016
   PubMed Web of Science ®Google Scholar
• Zhang SG, Xiong GL, Yang X. 益气补肾颗粒治疗慢性肾功能不全的初步实验及临床研究 [Preliminary experimental and clinical study of the treatment of chronic renal insufficiency by granule of yi-qi bu-shen]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992;12(6):335–7, 323. Chinese.
   PubMedGoogle Scholar
• Luo Y, Qin Z, Hong Z, et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett. 2004;363(3):218–223. doi:10.1016/j.neulet.2004.03.036
   PubMed Web of Science ®Google Scholar
• Mao XQ, Wu Y, Wu K, et al. Astragalus polysaccharide reduces hepatic endoplasmic reticulum stress and restores glucose homeostasis in a diabetic KKAy mouse model. Acta Pharmacol Sin. 2007;28(12):1947–1956. doi:10.1111/j.1745-7254.2007.00674.x
   PubMed Web of Science ®Google Scholar
• Wu Y, Ou-yang J-P, Wu K, et al. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacol Sin. 2005;26(3):345–352. doi:10.1111/j.1745-7254.2005.00062.x
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang Y, Sun S, et al. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can J Physiol Pharmacol. 2006;84(6):579–587. doi:10.1139/y06-015
   PubMed Web of Science ®Google Scholar
• Liu M, Wu K, Mao X, et al. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle. J Ethnopharmacol. 2010;127(1):32–37. doi:10.1016/j.jep.2009.09.055
   PubMed Web of Science ®Google Scholar
• Zou F, Mao XQ, Wang N, Liu J, Ou-Yang JP. Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK. Acta Pharmacol Sin. 2009;30(12):1607–1615.
   PubMed Web of Science ®Google Scholar
• Tang LQ, Wei W, Chen L-M, et al. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol. 2006;108(1):109–115. doi:10.1016/j.jep.2006.04.019
   PubMed Web of Science ®Google Scholar
• Bebrevska L, Foubert K, Hermans N, et al. In vivo antioxidative activity of a quantified Pueraria lobata root extract. J Ethnopharmacol. 2010;127(1):112–117. doi:10.1016/j.jep.2009.09.039
   PubMed Web of Science ®Google Scholar
• Herrmann N, Lanctot KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2004;16(3):261–276. doi:10.1176/jnp.16.3.261
   PubMed Web of Science ®Google Scholar
• Raskind MA, Peskind ER. Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994;8(Suppl 3):54–60. doi:10.1097/00002093-199404000-00005
   PubMed Web of Science ®Google Scholar
• Sontag TA, Hauser J, Kaunzinger I, Gerlach M, Tucha O, Lange KW. Effects of the noradrenergic neurotoxin DSP4 on spatial memory in the rat. J Neural Transm. 2008;115(2):299–303. doi:10.1007/s00702-007-0830-5
   PubMed Web of Science ®Google Scholar
• Weinshenker D. Long road to ruin: noradrenergic dysfunction in neurodegenerative disease. Trends Neurosci. 2018;41(4):211–223. doi:10.1016/j.tins.2018.01.010
   PubMed Web of Science ®Google Scholar
• Pillet LE, Taccola C, Cotoni J, et al. Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution. Transl Psychiatry. 2020;10(1):213. doi:10.1038/s41398-020-0841-7
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. Where, when, and in what form does sporadic Alzheimer’s disease begin? Curr Opin Neurol. 2012;25(6):708–714. doi:10.1097/WCO.0b013e32835a3432
   PubMed Web of Science ®Google Scholar
• Matthews KL, Chen CPL-H, Esiri MM, et al. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry. 2002;51(5):407–416. doi:10.1016/S0006-3223(01)01235-5
   PubMed Web of Science ®Google Scholar
• Martignoni E, Blandini F, Petraglia F, et al. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson’s disease, multiple system atrophy and dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect. 1992;4(3):191–205. doi:10.1007/BF02260903
   PubMedGoogle Scholar
• Tohgi H, Ueno M, Abe T, et al. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type. J Neural Transm Park Dis Dement Sect. 1992;4(1):69–77. doi:10.1007/BF02257623
   PubMedGoogle Scholar
• Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Effects of Alzheimer’s disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatry. 1997;154(1):25–30.
   PubMed Web of Science ®Google Scholar
• Gannon M, Che P, Chen Y, et al. Noradrenergic dysfunction in Alzheimer’s disease. Front Neurosci. 2015;9:220. doi:10.3389/fnins.2015.00220
   PubMed Web of Science ®Google Scholar
• Knecht S, Breitenstein C, Bushuven S, et al. Levodopa: faster and better word learning in normal humans. Ann Neurol. 2004;56(1):20–26. doi:10.1002/ana.20125
   PubMed Web of Science ®Google Scholar
• Shellshear L, MacDonald AD, Mahoney J, et al. Levodopa enhances explicit new-word learning in healthy adults: a preliminary study. Hum Psychopharmacol. 2015;30(5):341–349. doi:10.1002/hup.2480
   PubMed Web of Science ®Google Scholar
• Breitenstein C, Flöel A, Korsukewitz C, Wailke S, Bushuven S, Knecht S. A shift of paradigm: from noradrenergic to dopaminergic modulation of learning? J Neurol Sci. 2006;248(1–2):42–47. doi:10.1016/j.jns.2006.05.012
   PubMed Web of Science ®Google Scholar
• van der Velpen V, Teav T, Gallart-Ayala H, et al. Systemic and central nervous system metabolic alterations in Alzheimer’s disease. Alzheimers Res Ther. 2019;11(1):93. doi:10.1186/s13195-019-0551-7
   PubMed Web of Science ®Google Scholar
• Comai S, Bertazzo A, Brughera M, Crotti S. Tryptophan in health and disease. Adv Clin Chem. 2020;95:165–218.
   PubMed Web of Science ®Google Scholar